Personalized Dietary Regimens for Inflammatory Bowel Disease: Current Knowledge and Future Perspectives

被引:11
|
作者
Wellens, Judith [1 ,2 ]
Vissers, Eva [1 ]
Matthys, Christophe [3 ,4 ]
Vermeire, Severine [1 ,2 ]
Sabino, Joao [1 ,2 ]
机构
[1] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGID, Dept Chron Dis & Metab, Leuven, Belgium
[2] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium
[3] Univ Hosp Leuven, Dept Endocrinol, Clin Nutr Unit, Leuven, Belgium
[4] Katholieke Univ Leuven, Clin & Expt Endocrinol, Dept Chron Dis & Metab, Leuven, Belgium
关键词
inflammatory bowel disease; precision nutrition; nutritional therapy; personalized nutrition; CROHNS-DISEASE; ULCERATIVE-COLITIS; CLINICAL NUTRITION; EMULSIFIERS; MICROBIOME; METABOLISM; SYMPTOMS; IMPACT; RISK;
D O I
10.2147/PGPM.S359365
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Inflammatory bowel diseases (IBD) are chronic and incurable conditions of the gastro-intestinal tract with an increasing incidence and prevalence worldwide. Common symptoms are abdominal pain, diarrhea, and weight loss. Despite recent advances in medical management, many patients fail to achieve clinical remission and healing of the mucosa of the bowel. The cause is thought to involve an inappropriate reaction of the immune system, the microbiome and the environment in genetically susceptible individuals, leading to chronic bowel inflammation. Evidence is emerging that diet is a key environmental factor that might influence disease onset and course, and therefore may become a therapeutic strategy to mitigate inflammation and symptoms. Since IBD is a heterogeneous disease on a clinical and a molecular level, personalizing dietary advice could be the crucial factor to achieve long-lasting changes in dietary behaviors that could not only improve nutritional status but also tackle gut inflammation and abdominal symptoms on an individual level. In this review, we first discuss different aspects of personalized nutrition, namely the level, focus, and scope of personalized dietary regimens. Then, we provide a framework for the different goals of nutritional therapy in IBD and current evidence for personalized dietary approaches. Lastly, we discuss the need for adequate trial designs, access to the right data types and the bioinformatic tools that are necessary to develop algorithms that will allow us to move from general "healthy eating" advice to truly personalized nutritional plans for the individual IBD patient.
引用
收藏
页码:15 / 27
页数:13
相关论文
共 50 条
  • [21] Role of glucagon-like peptides in inflammatory bowel diseases-current knowledge and future perspectives
    Zatorski, Hubert
    Salaga, Maciej
    Fichna, Jakub
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 (11) : 1321 - 1330
  • [22] Dietary Patterns and Gut Microbiota Changes in Inflammatory Bowel Disease: Current Insights and Future Challenges
    Yan, Jing
    Wang, Lei
    Gu, Yu
    Hou, Huiqin
    Liu, Tianyu
    Ding, Yiyun
    Cao, Hailong
    NUTRIENTS, 2022, 14 (19)
  • [23] Common links between metabolic syndrome and inflammatory bowel disease: Current overview and future perspectives
    Michalak, Arkadiusz
    Mosinska, Paula
    Fichna, Jakub
    PHARMACOLOGICAL REPORTS, 2016, 68 (04) : 837 - 846
  • [24] Surveillance and management of colorectal dysplasia and cancer in inflammatory bowel disease: Current practice and future perspectives
    Wijnands, Anouk M.
    Mahmoud, Remi
    Lutgens, Maurice W. M. D.
    Oldenburg, Bas
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 93 : 35 - 41
  • [25] Common links between metabolic syndrome and inflammatory bowel disease: Current overview and future perspectives
    Arkadiusz Michalak
    Paula Mosińska
    Jakub Fichna
    Pharmacological Reports, 2016, 68 : 837 - 846
  • [26] The basis of current and future therapy for inflammatory bowel disease
    Elson, CO
    AMERICAN JOURNAL OF MEDICINE, 1996, 100 (06): : 656 - 662
  • [27] Interventional inflammatory bowel disease: current and future practice
    Clement, Benjamin
    Reyes Genere, Juan
    CURRENT OPINION IN GASTROENTEROLOGY, 2024, 40 (04) : 276 - 284
  • [28] Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseases
    Park, Sang Hyoung
    Park, Jae Cheol
    Lukas, Milan
    Kolar, Martin
    Loftus, Edward V., Jr.
    INTESTINAL RESEARCH, 2020, 18 (01) : 34 - 44
  • [29] Combination therapy in inflammatory bowel disease: Current evidence and perspectives
    Dai, Cong
    Huang, Yu-Hong
    Jiang, Min
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 114
  • [30] Gut microbiota and inflammatory bowel disease:The current status and perspectives
    Lie Zheng
    Xin-Li Wen
    World Journal of Clinical Cases, 2021, 9 (02) : 321 - 333